CS logo
small CS logo
Specjalistyczny Szpital im. dra Alfreda Sokolowskiego

Walbrzych, Poland
General hospital in Wałbrzych
Alfreda Sokołowskiego 4, 58-309 Wałbrzych

About Specjalistyczny Szpital im. dra Alfreda Sokolowskiego


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Specjalistyczny Szpital im. dra Alfreda Sokolowskiego


During the past decade, Specjalistyczny Szpital im. dra Alfreda Sokolowskiego conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Specjalistyczny Szpital im. dra Alfreda Sokolowskiego" #1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Pharmacyclics LLC." with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at Specjalistyczny Szpital im. dra Alfreda Sokolowskiego


According to Clinical.Site data, the most researched conditions in "Specjalistyczny Szpital im. dra Alfreda Sokolowskiego" are "Depressive Disorder, Major" (2 trials), "Multiple Myeloma" (2 trials), "Anemia" (1 trials), "Lymphoma, Mantle-Cell" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Specjalistyczny Szpital im. dra Alfreda Sokolowskiego" in a lesser frequency.

Clinical Trials Intervention Types at Specjalistyczny Szpital im. dra Alfreda Sokolowskiego


Most popular intervention types in "Specjalistyczny Szpital im. dra Alfreda Sokolowskiego" are "Drug" (8 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Bortezomib" (3 trials), "Placebo" (3 trials), "Daratumumab" (2 trials), "Dexamethasone" (2 trials) and "ACE-536" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Specjalistyczny Szpital im. dra Alfreda Sokolowskiego


The vast majority of trials in "Specjalistyczny Szpital im. dra Alfreda Sokolowskiego" are 8 trials for "All" genders.

Clinical Trials Status at Specjalistyczny Szpital im. dra Alfreda Sokolowskiego


Currently, there are NaN active trials in "Specjalistyczny Szpital im. dra Alfreda Sokolowskiego". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Specjalistyczny Szpital im. dra Alfreda Sokolowskiego, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Specjalistyczny Szpital im. dra Alfreda Sokolowskiego, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".